or Try an Advanced Search...

    ETF Components for OEUR - O'Shares FTSE Europe Quality Dividend ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVS D 0.26 3.81
    UL D -0.01 3.25
    ABBV F 2.12 2.36
    HSBH A 0.65 2.14
    DEO F -1.00 1.44

    Represented by ETF Holdings

    Keywords: Eye Care Products Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Alcohol Alcoholic Drinks American Depositary Receipt Anemia Animal Health Antibiotics Atopic Dermatitis Autoimmune Disease Beer Biotechnology Blood Cancers Blood Test Canadian Whisky Chronic Idiopathic Constipation Cleaning Products
    Industries: Drug Manufacturers - Major Beverages - Wineries & Distilleries Household & Personal Products

    Recent News for O'Shares FTSE Europe Quality Dividend ETF & its Holdings

    Date Stock Title
    Nov 21 DEO JOHNNIE WALKER RENEWS SUCCESSFUL LUNAR NEW YEAR PARTNERSHIP WITH VISIONARY ARTIST JAMES JEAN
    Nov 21 DEO Diageo “to pause” Crown Royal distillery construction in Canada
    Nov 21 UL Unilever silent amid talk private-equity sale of ice cream off table
    Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
    Nov 20 UL Unilever ends plans to sell ice cream business to private equity - FT
    Nov 20 DEO DELEÓN Tequila Unveils Its New Campaign and Brand Platform, "Bold Spirits, Rise"
    Nov 19 DEO Diageo: No Path For Market-Beating Returns
    Nov 19 ABBV Where Will AbbVie Be in 5 Years?
    Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
    Nov 19 DEO Casa Redondo eyes “more muscle” with M&A on back of Safari “party drink” purchase – CEO Daniel Redondo
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 UL Ben & Jerry’s sues parent company Unilever for stifling its stance on Gaza
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 19 ABBV RVPH: Year-End OLE Update
    Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
    Nov 18 ABBV AbbVie snaps eight straight sessions of losses
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
    Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
    The investment seeks to track the performance (before fees and expenses) of its target index, the FTSE Developed Europe Qual / Vol / Yield Factor 5% Capped Index (the "Europe Target Index"). The Europe Target Index is designed to measure the performance of publicly-listed large-capitalization and mid-capitalization dividend-paying issuers in Europe that meet certain market capitalization, liquidity, high quality, low volatility and dividend yield thresholds, as determined by FTSE-Russell (the "index provider"). Under normal market conditions, the fund will invest at least 80% of its total assets in the components of the Europe Target Index.
    Exchange Traded Fund ETF Index Fund Stock Market Index Dividend Dividend Yield Ftse 100 Index Europe/Consumer Discr Index
    Back to the Main OEUR Page...